SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-167951
Filing Date
2022-06-06
Accepted
2022-06-06 08:32:02
Documents
14
Period of Report
2022-06-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d309554d8k.htm   iXBRL 8-K 35590
2 EX-99.1 d309554dex991.htm EX-99.1 9357
6 GRAPHIC g309554g08e67.jpg GRAPHIC 3020
  Complete submission text file 0001193125-22-167951.txt   180784

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mirm-20220602.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20220602_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20220602_pre.xml EX-101.PRE 11707
8 EXTRACTED XBRL INSTANCE DOCUMENT d309554d8k_htm.xml XML 3472
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 22996771
SIC: 2834 Pharmaceutical Preparations